We read with interest the commentary manuscript on “Therapeutic Approaches of obstructive sleep apnea in China”.[1] This is an informative article summarizing how obstructive sleep apnea (OSA) is being treated in China. As in other countries, continuous positive airway pressure (CPAP) is the treatment of choice for moderate to severe OSA patients. The authors also described the use of oral appliance and mentioned the role of upper airway (UA) surgical procedures in the treatment of OSA. In addition, they correctly mentioned UA muscle training and hypoglossal nerve stimulation as alternative therapies for OSA. Unfortunately, the role of Positional Therapy (PT), that is, the avoidance of the supine posture during sleep in the treatment of OSA was not described. The authors mention in a single phrase “sleep position adjustment” among the effective therapeutic approaches but fail to provide further information on this mode of therapy.
We do not know the reason for this omission and we do not know how frequently PT is used in China, but it is important to realize that PT is a valuable therapeutic option for many OSA patients.
People with OSA comprise a heterogeneous group of patients, which are clearly not alike. Based on the effect of body posture on OSA, those patients are divided into positional patients (PP) who present breathing abnormalities only (isolated) or mainly (predominantly) in the supine posture (supine AHI at least double the lateral AHI) and non-positional patients (NPP) who have many breathing abnormalities in both lateral and supine postures (supine AHI less than double the lateral AHI). Compared to NPP, PP are thinner, somehow younger, have significantly less severe breathing abnormalities during sleep, enjoy a better sleep quality and are less sleepy during daytime.[2] This phenotype distinction between PP and NPP is crucial because PP may obtain substantial benefit from PT, since for them the severity of the disease is totally dependent on the sleep time spent or not spent in the supine posture.
The prevalence of PP determined in a sleep unit is about 56% and even higher for mild to moderate OSA (ranging from 65% to 69%).[2] In the Asian OSA patients, the prevalence of PP is even higher, reaching nearly 75%, and for mild OSA, as many as 87% are PP.[3] Therefore, the majority of Asian as well and non-Asian OSA patients are PP. Lately, a Swiss study assessed the prevalence and predictors of positional OSA in 1719 middle-older subjects of the general population and showed that 53% were PP. 71.2% had an Apnea Hypopnea Index≥ 5, among them 75% were PP (76% in women and 74% in men) and 36% had breathing abnormalities only in the supine posture.[4] Thus, probably after obesity, positional or supine-related OSA is the most dominant phenotype of adult OSA.
In the past, PT was a treatment with low adherence, but it has been improving significantly with the use of a new generation of devices, which appear much more comfortable amenable and effective for PP.[5]
Information on the use and adherence of PT in the Chinese OSA patients is highly needed.
Protective role of autophagy in triptolide-induced apoptosis of TM3 Leydig cells Chronic stress-induced immune dysregulation in breast cancer: Implications of psychosocial factors MiR-182/Sestrin2 affects the function of asthmatic airway smooth muscle cells by the AMPK/mTOR pathway Prevalence of left atrial septal pouch among patients with embolic stroke of undetermined source or stroke of known etiology: A retrospective study Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease Mitochondrial damage-associated molecular patterns in chronic obstructive pulmonary disease: Pathogenetic mechanism and therapeutic target Mesenchymal stem cells and connective tissue diseases: From bench to bedside A comprehensive weighted gene co-expression network analysis uncovers potential targets in diabetic kidney disease Hypervolemia suppresses dilutional anaemic injury in a rat model of haemodilution Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China Impact of the Alberta Stroke Program CT Score subregions on long-term functional outcomes in acute ischemic stroke: Results from two multicenter studies in China Prognostic value of serum ammonia in critical patients with non-hepatic disease: A prospective, observational, multicenter study Associations of gallbladder and gallstone parameters with clinical outcomes in patients with cirrhosis Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma Single photon emission computed tomography/computed tomography imaging of gouty arthritis: A new voice Manipulating cell motility by Legionella : Speeding up or slowing down?Moderate-intensity continuous training has time-specific effects on the lipid metabolism of adolescents Comprehensive succinylome analyses reveal that hyperthermia upregulates lysine succinylation of annexin A2 by downregulating sirtuin7 in human keratinocytes Standardized inhalation capability assessment: A key to optimal inhaler selection for inhalation therapy Inhibition of heterogeneous nuclear ribonucleoproteins A1 and oxidative stress reduces glycolysis via pyruvate kinase M2 in chronic thromboembolic pulmonary hypertensionEffective albumin – A novel paradigm in the management of decompensated liver cirrhosis Long-term blood pressure outcomes of laparoscopic adrenalectomy in trHTN patients Retraction note: Hydrogel: A promising new technique for treating Alzheimer’s disease (in Volume 10 Issue 3)